AU3238102A - Estrogen receptor modulators - Google Patents

Estrogen receptor modulators

Info

Publication number: AU3238102A
Authority: AU; Australia
Prior art keywords: estrogen receptor; receptor modulators; modulators; estrogen; receptor
Prior art date: 2000-10-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

AU3238102A

Other languages

English (en)

Inventor

Frank P Dininno

Helen Y Chen

Seongkon Kim

Jane Y Wu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck and Co Inc

Original Assignee

Merck and Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-19

Filing date

2001-10-15

Publication date

2002-04-29

2001-10-15 Application filed by Merck and Co Inc filed Critical Merck and Co Inc

2002-04-29 Publication of AU3238102A publication Critical patent/AU3238102A/xx

Status Pending legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Oncology (AREA)
Reproductive Health (AREA)
Child & Adolescent Psychology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

AU3238102A 2000-10-19 2001-10-15 Estrogen receptor modulators Pending AU3238102A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US24158200P	2000-10-19	2000-10-19
PCT/US2001/042735 WO2002032377A2 (en)	2000-10-19	2001-10-15	Estrogen receptor modulators

Publications (1)

Publication Number	Publication Date
AU3238102A true AU3238102A (en)	2002-04-29

Family

ID=22911282

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2002232381A Ceased AU2002232381B2 (en)	2000-10-19	2001-10-15	Estrogen receptor modulators
AU3238102A Pending AU3238102A (en)	2000-10-19	2001-10-15	Estrogen receptor modulators

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU2002232381A Ceased AU2002232381B2 (en)	2000-10-19	2001-10-15	Estrogen receptor modulators

Country Status (20)

Country	Link
EP (1)	EP1333827A2 (xx)
JP (1)	JP2004511502A (xx)
KR (1)	KR20030042020A (xx)
CN (1)	CN1469743A (xx)
AU (2)	AU2002232381B2 (xx)
BG (1)	BG107676A (xx)
BR (1)	BR0114689A (xx)
CA (1)	CA2424729A1 (xx)
EA (1)	EA200300474A1 (xx)
EC (1)	ECSP034558A (xx)
EE (1)	EE200300153A (xx)
HU (1)	HUP0303563A2 (xx)
IL (1)	IL154984A0 (xx)
IS (1)	IS6761A (xx)
MX (1)	MXPA03003485A (xx)
NO (1)	NO20031737L (xx)
PE (1)	PE20021083A1 (xx)
PL (1)	PL361053A1 (xx)
SK (1)	SK4772003A3 (xx)
WO (1)	WO2002032377A2 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030225132A1 (en) *	2002-04-11	2003-12-04	Dininno Frank P.	Estrogen receptor modulators
JP4554219B2 (ja)	2002-04-24	2010-09-29	メルク・シャープ・エンド・ドーム・コーポレイション	エストロゲン受容体調節剤
NZ535705A (en)	2002-05-10	2007-08-31	Hoffmann La Roche	Ibandronic acid for the treatment and prevention of osteoporosis
EP1577288B1 (en) *	2002-12-26	2014-07-23	Eisai R&D Management Co., Ltd.	Selective estrogen receptor modulators
CN101365446B (zh)	2005-07-29	2013-05-22	雷斯弗洛吉克斯公司	预防和治疗复杂疾病的药物组合物及其经由可植入医药装置的递送
AU2006307046A1 (en) *	2005-10-27	2007-05-03	Msd K.K.	Novel benzoxathiin derivative
PL2118074T3 (pl)	2007-02-01	2014-06-30	Resverlogix Corp	Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego
JP5635535B2 (ja)	2009-01-08	2014-12-03	レスバーロジックスコーポレイション	心血管疾患の予防および治療のための化合物
WO2010106436A2 (en)	2009-03-18	2010-09-23	Resverlogix Corp.	Novel anti-inflammatory agents
TR201818390T4 (tr)	2009-04-22	2019-01-21	Resverlogix Corp	Yeni̇ anti̇-i̇nflamatuvar ajanlar
DK2580210T5 (en)	2010-06-10	2017-06-19	Seragon Pharmaceuticals Inc	ESTROGEN RECEPTOR MODULATORS AND APPLICATIONS THEREOF
US8853423B2 (en)	2010-06-17	2014-10-07	Seragon Pharmaceuticals, Inc.	Indane estrogen receptor modulators and uses thereof
TR201909777T4 (tr)	2011-11-01	2019-07-22	Resverlogix Corp	Sübsti̇tüe ki̇nazoli̇nonlara yöneli̇k oral çabuk salimli formülasyonlar
WO2013090829A1 (en)	2011-12-14	2013-06-20	Aragon Pharmaceuticals, Inc.	Estrogen receptor modulators and uses thereof
US9765039B2 (en)	2012-11-21	2017-09-19	Zenith Epigenetics Ltd.	Biaryl derivatives as bromodomain inhibitors
WO2014080290A2 (en)	2012-11-21	2014-05-30	Rvx Therapeutics Inc.	Cyclic amines as bromodomain inhibitors
WO2014096965A2 (en)	2012-12-21	2014-06-26	Rvx Therapeutics Inc.	Novel heterocyclic compounds as bromodomain inhibitors
US10111885B2 (en)	2015-03-13	2018-10-30	Resverlogix Corp.	Compositions and therapeutic methods for the treatment of complement-associated diseases

2001
- 2001-10-15 BR BR0114689-0A patent/BR0114689A/pt not_active Application Discontinuation
- 2001-10-15 JP JP2002535616A patent/JP2004511502A/ja not_active Withdrawn
- 2001-10-15 MX MXPA03003485A patent/MXPA03003485A/es unknown
- 2001-10-15 KR KR10-2003-7005518A patent/KR20030042020A/ko not_active Withdrawn
- 2001-10-15 EP EP01987654A patent/EP1333827A2/en not_active Withdrawn
- 2001-10-15 IL IL15498401A patent/IL154984A0/xx unknown
- 2001-10-15 SK SK477-2003A patent/SK4772003A3/sk unknown
- 2001-10-15 EA EA200300474A patent/EA200300474A1/ru unknown
- 2001-10-15 HU HU0303563A patent/HUP0303563A2/hu unknown
- 2001-10-15 CN CNA018176720A patent/CN1469743A/zh active Pending
- 2001-10-15 EE EEP200300153A patent/EE200300153A/xx unknown
- 2001-10-15 WO PCT/US2001/042735 patent/WO2002032377A2/en not_active Ceased
- 2001-10-15 PL PL01361053A patent/PL361053A1/xx not_active Application Discontinuation
- 2001-10-15 AU AU2002232381A patent/AU2002232381B2/en not_active Ceased
- 2001-10-15 AU AU3238102A patent/AU3238102A/xx active Pending
- 2001-10-15 CA CA002424729A patent/CA2424729A1/en not_active Abandoned
2002
- 2002-04-15 PE PE2002000308A patent/PE20021083A1/es not_active Application Discontinuation
2003
- 2003-03-26 BG BG107676A patent/BG107676A/bg unknown
- 2003-03-27 IS IS6761A patent/IS6761A/is unknown
- 2003-04-15 NO NO20031737A patent/NO20031737L/no unknown
- 2003-04-17 EC EC2003004558A patent/ECSP034558A/es unknown

Also Published As

Publication number	Publication date
WO2002032377A3 (en)	2002-08-22
HUP0303563A2 (hu)	2004-03-01
WO2002032377A2 (en)	2002-04-25
AU2002232381B2 (en)	2004-11-18
MXPA03003485A (es)	2003-07-14
CN1469743A (zh)	2004-01-21
ECSP034558A (es)	2003-06-25
BR0114689A (pt)	2003-07-01
BG107676A (bg)	2003-11-28
JP2004511502A (ja)	2004-04-15
SK4772003A3 (en)	2003-08-05
IS6761A (is)	2003-03-27
PL361053A1 (en)	2004-09-20
PE20021083A1 (es)	2002-12-16
EE200300153A (et)	2003-06-16
EP1333827A2 (en)	2003-08-13
KR20030042020A (ko)	2003-05-27
CA2424729A1 (en)	2002-04-25
NO20031737L (no)	2003-06-19
EA200300474A1 (ru)	2003-10-30
NO20031737D0 (no)	2003-04-15
IL154984A0 (en)	2003-10-31

Publication	Publication Date	Title
PL374215A1 (en)	2005-10-03	Selective estrogen receptor modulators
EG25606A (en)	2012-03-20	Glucocorticoid receptor modulators
IL150912A0 (en)	2003-02-12	Adenosine receptor modulators
EP1200581A4 (en)	2003-04-02	TRUNK EGF RECEPTOR
AU3238102A (en)	2002-04-29	Estrogen receptor modulators
IL146151A0 (en)	2002-07-25	Human-g-protein receptor
IL162295A0 (en)	2005-11-20	Tetracyclic heterocompounds as estrogen receptor modulators
AU2003231523A1 (en)	2003-10-27	Estrogen receptor modulators
GB0000474D0 (en)	2000-03-01	Receptor
AU1252102A (en)	2002-05-21	Receptor
AUPQ563400A0 (en)	2000-03-09	Novel receptor
GB2363887B (en)	2004-02-11	Mailer-postal service interfaces
GB9913649D0 (en)	1999-08-11	Estrogen receptor
IL142881A0 (en)	2002-03-10	Enzymatic resolution of selective estrogen receptor modulators
GB0100299D0 (en)	2001-02-14	Estrogen receptor
GB0100298D0 (en)	2001-02-14	Estrogen receptor
GB0100301D0 (en)	2001-02-14	Estrogen receptor
AU2002252533A1 (en)	2002-10-15	Estrogen receptor modulators
SI1467998T1 (sl)	2006-08-31	Tetraciklicne heterospojine kot modulatorji estrogenskega receptorja
GB0016230D0 (en)	2000-08-23	Estrogen receptors
GB0014761D0 (en)	2000-08-09	Receptor
GB0009269D0 (en)	2000-05-31	Receptor
GB0031096D0 (en)	2001-01-31	Receptor
GB9806032D0 (en)	1998-05-20	Estrogen receptor
AU2002249971A1 (en)	2002-09-24	Piperazinyltriazines as estrogen receptor modulators